81 related articles for article (PubMed ID: 8368721)
1. [Classification of dyslipoproteinemias of genetic origin].
Brousseau T; Fruchart JC
Ann Med Interne (Paris); 1993; 144(4):275-81. PubMed ID: 8368721
[No Abstract] [Full Text] [Related]
2. Classification of primary dyslipoproteinemias.
Dargel R
Exp Pathol; 1985; 27(2):67-78. PubMed ID: 3888651
[No Abstract] [Full Text] [Related]
3. Genetic determinants of dyslipidemias.
Breslow JL
Monogr Atheroscler; 1985; 13():25-31. PubMed ID: 3937050
[No Abstract] [Full Text] [Related]
4. [Dyslipoproteinemias and coronary disease. Genetic markers].
Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
[TBL] [Abstract][Full Text] [Related]
5. [Apolipoproteinopathies].
Assmann G
Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
[No Abstract] [Full Text] [Related]
6. [Hypo- and hyperalphalipoproteinemia and genetic abnormalties in reverse cholesterol transport system].
Matsuyama A; Yamashita S
Nihon Rinsho; 2001 Feb; 59 Suppl 2():539-44. PubMed ID: 11351645
[No Abstract] [Full Text] [Related]
7. [Classification of primary dyslipoproteinemias].
Ziegler O; Jan P; Got I; Drouin P
Ann Cardiol Angeiol (Paris); 1989 May; 38(5):243-8. PubMed ID: 2735737
[TBL] [Abstract][Full Text] [Related]
8. Genetics of lipoprotein disorders.
Breslow JL
Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
[TBL] [Abstract][Full Text] [Related]
9. Clinical disorders of lipoprotein metabolism.
Brewer HB; Gregg RE; Hoeg JM; Law S
Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
[No Abstract] [Full Text] [Related]
10. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters].
Herrmann W; Lackner KJ; Schmitz G
Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932
[TBL] [Abstract][Full Text] [Related]
11. [Genetic aspects of primary atherogenic dyslipoproteinemia].
Turpin G; Bruckert E
C R Seances Soc Biol Fil; 1995; 189(5):905-17. PubMed ID: 8673636
[TBL] [Abstract][Full Text] [Related]
12. [Genetic aspects of atherogenic dyslipoproteinemias].
de Gennes JL
Ann Biol Clin (Paris); 1986; 44(5):556-8. PubMed ID: 3813140
[TBL] [Abstract][Full Text] [Related]
13. Some clinical implications of the results of the Lipid Research Clinics Program Prevalence Study.
LaRosa JC; Levy RI; Hazzard WR
Circulation; 1986 Jan; 73(1 Pt 2):I126-33. PubMed ID: 3940680
[No Abstract] [Full Text] [Related]
14. Heterogeneity of high density lipoprotein particles.
Fruchart JC; Ailhaud G; Bard JM
Circulation; 1993 Apr; 87(4 Suppl):III22-7. PubMed ID: 8462177
[TBL] [Abstract][Full Text] [Related]
15. A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.
de Graaf J; Couture P; Sniderman A
Nat Clin Pract Endocrinol Metab; 2008 Nov; 4(11):608-18. PubMed ID: 18838971
[TBL] [Abstract][Full Text] [Related]
16. Genetics of lipoprotein disorders.
Davignon J; Genest J
Endocrinol Metab Clin North Am; 1998 Sep; 27(3):521-50. PubMed ID: 9785051
[TBL] [Abstract][Full Text] [Related]
17. [The relationship of apoB gene polymorphism to dyslipoproteinemia as the cause of atherosclerosis].
Kravchenko NA
Tsitol Genet; 1995; 29(4):84-7. PubMed ID: 8604528
[TBL] [Abstract][Full Text] [Related]
18. [Genetically caused and rare forms of dyslipoproteinemias].
Lipovetslkiĭ BM; Trofanov VF
Klin Med (Mosk); 1984 Nov; 62(11):102-8. PubMed ID: 6521363
[No Abstract] [Full Text] [Related]
19. Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy.
Seripa D; Gravina C; Volpe R; Margaglione M; Papa S; Merla G; Parrella P; Di Minno G; Ricci G; Testa M; Fazio VM
J Inherit Metab Dis; 1999 Jun; 22(5):670-1. PubMed ID: 10399102
[No Abstract] [Full Text] [Related]
20. Apolipoprotein A1 and B.
Sniderman AD; Marcovina SM
Clin Lab Med; 2006 Dec; 26(4):733-50. PubMed ID: 17110237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
